Sanofi Seeks Independence For API Unit Despite Stormy Market
IPO Plans Shelved In Favor Of Spin-Off
The French drugmaker is pushing ahead with a listing of its Euroapi business on the Euronext in the next couple of months, in spite of the turbulence that the Russian invasion of Ukraine has brought to stock markets.
